Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.
Stem Cell Res Ther
; 13(1): 180, 2022 05 03.
Article
in En
| MEDLINE
| ID: mdl-35505375
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Mesenchymal Stem Cells
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Stem Cell Res Ther
Year:
2022
Document type:
Article